Cells, people and approval
What the cell work shows
In cells grown in dishes, researchers found longer telomeres after epitalon; these are caps on the ends of the threads that carry a cell’s instructions.
Those cell findings do not show that a person will age more slowly.
- Ask whether the advertised result came from cells or people.
- Ask what health outcome would demonstrate the claimed benefit.
What the human work can answer
FDA means the US medicines agency.
FDA’s July 2026 review located three human epitalon studies: work in night-shift workers and in people with an inherited eye disease.
None of that work measured whether epitalon extended human lifespan.
No human study in that review used epitalon injected under the skin.
- Were the people in the study being treated for the same concern I have?
- Did they use the medicine in the same way, such as a spray or a shot?
- Did researchers measure the change being promised to me?
- Ask what the study did not measure.
Status is a separate question
Epitalon had no US drug approval at the September 28, 2026 check.
FDA staff recommended keeping epitalon off the list that names additional ingredients regular pharmacies may use, in their July 2026 briefing.
A staff recommendation is advice; changing that list takes a separate formal rule process.
- Ask for the rule relied on by anyone offering it.
- Read the separate checks on unknown effects and ingredient status.
Sources for this page
Sources checked through September 28, 2026.